Transarterial Chemoembolization (TACE) Plus Sorafenib Compared to TACE Alone in Transplant Recipients with Hepatocellular Carcinoma: An Institution Experience

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third most common cause of cancer-related mortality worldwide. Transarterial chemoembolization has shown survival benefits in patients with early to intermediate-stage HCC, becoming the standard of care and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelrahim, Maen, Victor, David, Esmail, Abdullah, Kodali, Sudha, Graviss, Edward A., Nguyen, Duc T., Moore, Linda W., Saharia, Ashish, McMillan, Robert, Fong, Joy N., Uosef, Ahmed, Elshawwaf, Mahmoud, Heyne, Kirk, Ghobrial, Rafik M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833802/
https://www.ncbi.nlm.nih.gov/pubmed/35158918
http://dx.doi.org/10.3390/cancers14030650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833802/
https://www.ncbi.nlm.nih.gov/pubmed/35158918
http://dx.doi.org/10.3390/cancers14030650

Ejemplares similares